Delivery Order SPE2DB20D3103-SPE2DB24FN4U0
Award Date
4/17/24
Potential Completion Date
4/18/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm-fixed-price contract is for the supply of Omnipaque 350 mg/ml infusion bottles (100 ml). The contract has an ultimate completion date of January 19, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Omnipaque 350 mg/ml pluspak 500ml, a contrast agent used in medical imaging procedures. The $1,399.28 firm-fixed-price contract has a period of performance through July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The award, valued at $2,218.08, is for the delivery of Omnipaque 300 mg/mL medical imaging contrast media, which is used to enhance the visibility of internal body structures during medical procedures. The contract is a firm-fixed-price delivery order with a period of performance ending on September 24, 2024. It is not designated as...
This federal contract award is for the delivery of Omnipaque 350 mg/ml infusion bottles (150 ml) to the Defense Logistics Agency (DLA). The $1,783.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 25, 2022 and was awarded on January 24, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,909.55, is a delivery order for the supply of Omnipaque 350 mg/ml infusion bottles (100 ml). The contract has a completion date of December 31, 2024 and uses a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Omnipaque 350 mg/ml infusion bottles. The contract is a delivery order with a firm fixed price of $1,653.50 and a completion date of May 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award...
This $3,499.65 firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Omnipaque 300 mg/mL infusion bottles, a medical product used in federal healthcare programs. The contract is not designated as a set-aside and represents a direct award to AmerisourceBergen, which holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical product, with a ceiling value of $1,147.37 and a performance period through May 15, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,837.80 delivery order is for OMNIPAQUE 350 MG/ML intravenous infusion bottles, with a completion date of September 6, 2022. The contract is a firm-fixed price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,218.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipaque 350 mg/ml infusion bottles, a critical pharmaceutical product. The award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...